Skip to main content
Premium Trial:

Request an Annual Quote

BioDiscovery Licenses GeneSight Software to TMRI

NEW YORK, Aug. 28 – Software developer BioDiscovery said Tuesday that it had granted a site license for its GeneSight software to the Torrey Mesa Research Institute.

GeneSight is designed to allow researchers to analyze gene expression data, combining various statistical tools and visualization capabilities. 

"Our microarray facility produces a vast amount of expression data daily, and hosts one of the largest expression databases in agricultural genomics. We need a comprehensive statistical analysis tool that is easy to use and platform independent for our large-scale data analysis projects," Tong Zhu, head of TMRI’s microarray group, said in a statement. 

TMRI of San Diego is a wholly owned subsidiary of Syngenta, an agribusiness.

In addition to GeneSight, BioDiscovery of Marina Del Rey, Calif., also sells ImaGene, a microarray image processing and analysis tool for microarrays, and CloneTracker, a data management program used for microarray fabrication and production.

BioDiscovery did not disclose the financial terms for the site license.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.